Search research articles
Contact Us
Filters
Showing results (201-210 of 213) with videos related to
Page
of 22
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 29, 2023
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain
Lekha Mikkilineni, Danielle A Natrakul, Norris Lam, et al.
Blood Advances
|
December 7, 2020
NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease
Suk See De Ravin, Julie Brault, Ronald J Meis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2022
Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
Daniel S Green, Franklin Ning, Anna Duemler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2023
Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
Daniel S Green, Franklin Ning, Anna Duemler, et al.
Blood
|
September 15, 2021
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells
Daniel A Lichtenstein, Fiorella Schischlik, Lipei Shao, et al.
Cytotherapy
|
November 5, 2025
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies
Alexandra Dreyzin, Anne Marijn Kramer, Bonnie Yates, et al.
Cell
|
May 1, 2026
Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse
Luca Gattinoni, Gabriele Inchingolo, Dennis C Harrer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 28, 2015
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers
Bronwen E Shaw, Brent R Logan, Deidre M Kiefer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 30, 2017
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34<sup>+</sup> Yields Are Less
David F Stroncek, Bronwen E Shaw, Brent R Logan, et al.
Journal of Translational Medicine
|
November 17, 2016
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015
Paolo A Ascierto, Sanjiv Agarwala, Gerardo Botti, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 213) with videos related to
Sort By:
Page
of 22
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 29, 2023
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain
Lekha Mikkilineni, Danielle A Natrakul, Norris Lam, et al.
Blood Advances
|
December 7, 2020
NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease
Suk See De Ravin, Julie Brault, Ronald J Meis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2022
Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
Daniel S Green, Franklin Ning, Anna Duemler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2023
Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
Daniel S Green, Franklin Ning, Anna Duemler, et al.
Blood
|
September 15, 2021
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells
Daniel A Lichtenstein, Fiorella Schischlik, Lipei Shao, et al.
Cytotherapy
|
November 5, 2025
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies
Alexandra Dreyzin, Anne Marijn Kramer, Bonnie Yates, et al.
Cell
|
May 1, 2026
Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse
Luca Gattinoni, Gabriele Inchingolo, Dennis C Harrer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 28, 2015
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers
Bronwen E Shaw, Brent R Logan, Deidre M Kiefer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 30, 2017
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34<sup>+</sup> Yields Are Less
David F Stroncek, Bronwen E Shaw, Brent R Logan, et al.
Journal of Translational Medicine
|
November 17, 2016
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015
Paolo A Ascierto, Sanjiv Agarwala, Gerardo Botti, et al.
Page
of 22